Biomarkers for gastric cancer: Progression in early diagnosis and prognosis

被引：90
作者：
Jin, Ziliang [1 ]
Jiang, Weihua [1 ]
Wang, Liwei [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Oncol, Shanghai Key Lab Pancreat Dis, Shanghai 200080, Peoples R China
来源：
ONCOLOGY LETTERS | 2015年 / 9卷 / 04期
基金：
中国国家自然科学基金;
关键词：
gastric cancer; early diagnosis; prognosis; biological marker; GROWTH-FACTOR RECEPTORS; POOR-PROGNOSIS; MICROSATELLITE INSTABILITY; PROMOTER METHYLATION; EPIGENETIC ALTERATION; POTENTIAL BIOMARKERS; CLINICAL-IMPLICATION; SERUM INTERLEUKIN-6; CELL-PROLIFERATION; GENE POLYMORPHISMS;
D O I：
10.3892/ol.2015.2959
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Gastric cancer is one of leading causes of cancer-related mortality worldwide and is a notable disease due to its heterogeneity. Recently, numerous studies have investigated the molecular basis of gastric cancer, involving the alteration of pathogenesis, and invasion and metastasis. With the development of modern technologies, various novel biomarkers had been identified that appear to possess diagnostic and prognostic value; therefore, the present review describes our current knowledge of biomarkers for the early diagnosis and prognosis of gastric cancer. Classic biomarkers for gastric cancer diagnosis include carcinoembryonic antigen and cancer antigen 19-9, while microRNA and DNA hypomethylation are proposed as novel biomarkers. Excluding classical biomarkers, biomarkers for determining the progression and prognosis of gastric cancer focus on targeting microRNAs, epigenetic alterations and genetic polymorphisms.
引用
收藏
页码：1502 / 1508
页数：7
相关论文
共 116 条
  • [1] Aizawa K, 1999, INT J ONCOL, V14, P85
  • [2] The prognostic significance of p53, p27kip1, p21waf1, HER-2/neu, and ki67 proteins expression in gastric cancer:: A clinicopathological and lmmunohistochemical study of 121 Arab patients
    Al-Moundhri, MS
    Nirmala, V
    Al-Hadabi, I
    Al-Mawaly, K
    Burney, I
    Al-Nabhani, M
    Thomas, V
    Ganguly, SS
    Grant, C
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2005, 91 (04) : 243 - 252
  • [3] c-Met expression in gastric cancer with liver metastasis
    Amemiya, H
    Kono, K
    Itakura, J
    Tang, RF
    Takahashi, A
    An, FQ
    Kamei, S
    Iizuka, H
    Fujii, H
    Matsumoto, Y
    [J]. ONCOLOGY, 2002, 63 (03) : 286 - 296
  • [4] [Anonymous], SCIENTIFICWORLDJOURN, DOI [10.1100/2012/761909226060613353315, DOI 10.1100/2012/761909226060613353315]
  • [5] Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: Role of IL-6 as a prognostic factor
    Ashizawa T.
    Okada R.
    Suzuki Y.
    Takagi M.
    Yamazaki T.
    Sumi T.
    Aoki T.
    Ohnuma S.
    Aoki T.
    [J]. Gastric Cancer, 2005, 8 (2) : 124 - 131
  • [6] Prognostic Role of Host Cyclooxygenase and Cytokine Genotypes in a Caucasian Cohort of Patients with Gastric Adenocarcinoma
    Asuncion Garcia-Gonzalez, Maria
    Nicolas-Perez, David
    Lanas, Angel
    Bujanda, Luis
    Carrera, Patricia
    Benito, Rafael
    Strunk, Mark
    Sopena, Federico
    Santolaria, Santos
    Piazuelo, Elena
    Jimenez, Pilar
    Campo, Rafael
    Espinel, Jesus
    Manzano, Marisa
    Geijo, Fernando
    Pellise, Maria
    Gonzalez-Huix, Ferran
    Espinos, Jorge
    Zaballa, Manuel
    Tito, Llucia
    Barranco, Luis
    Pazo, Roberto
    Quintero, Enrique
    [J]. PLOS ONE, 2012, 7 (09):
  • [7] Aurello P, 2009, AM SURGEON, V75, P1183
  • [8] Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer
    Cai, Hui
    Yuan, Yuan
    Hao, Yun-Fei
    Guo, Tian-Kang
    Wei, Xue
    Zhang, Ying-Mei
    [J]. MEDICAL ONCOLOGY, 2013, 30 (01)
  • [9] Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells
    Cao, Weiguo
    Fan, Rong
    Wang, Lifu
    Cheng, Shidan
    Li, Hao
    Jiang, Jinsong
    Geng, Mei
    Jin, Yening
    Wu, Yunlin
    [J]. TUMOR BIOLOGY, 2013, 34 (02) : 963 - 971
  • [10] Che XM, 2000, CANCER-AM CANCER SOC, V89, P1214
12345678910